Objectives The purpose of this retrospective observational study is to report author's experience in computed-tomography (CT)-guided percutaneous vertebroplasty (PV) of the cervicothoracic junction. Methods The records of all consecutive patients treated by PV at levels C7, T1, T2, and T3 in a tertiary cancer center during year 2020 were extracted from the Institutional electronic archive. Following data were collected: demographics, indication for PV, procedure features, outcomes, and complications. Technical success was defined as when the trocar was placed into the vertebral body, allowing the injection of polymethyl-metacrylate (PMMA). Results Eleven patients were identified who received PV on 14 levels. Mean procedure duration was 57 ± 22 min (range ). A ''trans-pedicular approach at the targeted level'' was used in 1 vertebra (7%), a ''costotransverse approach, at the targeted level'' was used in 1 vertebra (7%), a ''transpedicular approach via the level below'' was used in 3 vertebrae (22%), and a ''costotransverse approach via the level below'' was used in 9 vertebrae (64%). Meantime to deploy each trocar was 20 ± 5 min (range ). Technical success was achieved in 14/14 (100%) of vertebrae. Mean postoperative hospitalization duration was 1.9 ± 1.7 days (range [1][2][3][4][5][6][7][8][9][10][11]). According to CIRSE classification, no adverse event occurred. PMMA leakage occurred in two patients; both remained asymptomatic. Conclusion This study provides arguments in favor of safety and efficiency of CT-guided vertebroplasty of levels C7, T1, T2, and T3, for both trocar deployment and monitoring of the vertebral body filling during the PMMA injection.